carteolol - CISMeF

Preferred Label : carteolol;

MeSH definition : A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.;

MeSH hyponym : OPC-1085; carteolol hydrochloride; OPC 1085; OPC1085; Hydrochloride, Carteolol; Carteolol Monohydrochloride; Monohydrochloride, Carteolol;

MeSH CAS label : 2(1H)-Quinolinone, 5-(3-((1,1-dimethylethyl)amino)-2-hydroxypropoxy)-3,4-dihydro-;

MeSH Related Number : carteolol hydrochloride; 51781-06-7 (Carteolol); 51781-21-6 (mono HCl); 4797W6I0T4;

Registry Number MeSH : 51781-06-7;

Related CAS MeSH : 4797W6I0T4 (Carteolol hydrochloride);

Wikipedia link : https://en.wikipedia.org/wiki/Carteolol;

Is substance : O;

UNII : 8NF31401XG;

InChIKey : LWAFSWPYPHEXKX-UHFFFAOYSA-N;

Details

Origin ID

D002354;

UMLS CUI

C0007299;

ATC code(s)
- carteolol [ATC Code]
- carteolol, combinations [ATC Code]
ATC code(s)
- carteolol [ATC Code]
- carteolol [ATC Code]
- carteolol, combinations [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Carteolol [ICHI extension code]
- Carteolol Hydrochloride [NCIt concept]
- Carteolol hydrochloride (substance) [SNOMED CT concept]
CISMeF manual mappings
- Carteolol adverse reaction (disorder) [SNOMED CT concept]
Pharmacological action(s)
- adrenergic beta-antagonists [MeSH Descriptor]
- anti-arrhythmia agents [MeSH Descriptor]
- antihypertensive agents [MeSH Descriptor]
- peripheral nervous system agents [MeSH Descriptor]
- sympatholytics [MeSH Descriptor]
Record concept(s)
- OPC-1085 [MeSH concept]
- carteolol [MeSH concept]
- carteolol hydrochloride [MeSH concept]
Related MeSH Supplementary Concept(s)
- 1-methylcarteolol [MeSH Supplementary Concept]
- 8-hydroxycarteolol [MeSH Supplementary Concept]
See also inter- (CISMeF)
- Product containing carteolol (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Carteolol [ICD-11 Extension code]
- Carteolol [NCIt concept]
- Carteolol (substance) [SNOMED CT concept]
- Product containing carteolol (medicinal product) [SNOMED CT concept]
- carteolol [ATC Code]
- carteolol [ATC Code]
Validated automatic mappings to BTNT
- 5-[3-[(TERT-BUTYL)AMINO]-2-HYDROXYPROPOXY]-3,4-DIHYDRO-2-QUINOLONE MONOHYDROCHLORIDE [Substance BNPC]
- Carteolol Hydrochloride [NCIt concept]
- Carteolol hydrochloride (substance) [SNOMED CT concept]
- carteolol [ATC Code]
- carteolol [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients